
FDAã¯é«éœ¢è ãæšçãšããçç©å µåšãæ¿èªããŸãã â 圌ãã¯ãããã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãšåŒãã§ããŸã
å èšäºã¯ãã¡ããã/Click here to read the original article.
FDAã¯ã¯ã¯ãã³ã§ã¯ãªãå µåšãæ¿èªããã ãã§ã
(æèŠ)6æ18æ¥ãFDAã®ã¯ã¯ãã³è«®åå§å¡äŒã¯ã50æ³ãã64æ³ã®æäººããã³65æ³ä»¥äžã®äººã ã«å¯ŸããŠã¢ãã«ãã®mRNAã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãæšå¥šããããšã9察0ã§æ±ºå®ããŸãã[1]ãççŽã«èšããŸãããããã¯ã¯ã¯ãã³ã§ã¯ãããŸãããããã¯ãã®æ¿åºãæãè³éæäŸãæãŸãªã人ã ãæé€ããããšãç®çãšããçç©å µåšã§ããã圌ãã¯ããããã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ããšåŒã¶ããã«èšãããã£ãŠããŸãããªããªãããããæ¥åžžçã«èãããããã§ããæç¥šã¯å šäŒäžèŽã§ããããæãããããæ©é¢å ã§ã®å šäŒäžèŽã¯å®å šã®èšŒæ ã§ã¯ãããŸãããäžçŽç ç©¶ç§åŠè ã®ã«ãŒã«ã»ã€ããããã¹ãæ°ãè¿°ã¹ãããã«ããå šäŒäžèŽã®æç¥šã«ããã害ã®å€ããåžè²©åŸæéã«çããªããã°ãªããªãããšãä¿èšŒãããŸãããã®å®³ã人å£ã«çŸããææã§ãã[2]ã
ãã®mRNA泚å°ãã¯ã¯ãã³ãšåŒã¶ã®ã¯åã ãšæããŸãã西æŽã®ããŠã€ã«ã¹åŠãã®èãæ¹ã§ãããæ¬åœã®ã¯ã¯ãã³ã¯ç åäœã«å¯ŸããŠå ç«ã·ã¹ãã ãèšç·ŽããŸããããããã®æè¡ã¯èªåã®çްèãä¹ã£åããç°æã®ã¿ã³ãã¯è³ªã補é ãããŠããŸããŸãããšã©ãã»ããªãŒã©ã³ããããžãªãšã³ãžãã¢ãªã³ã°ããããã©ã³ã¹ãã¥ãŒãããºã ãã§ç€ºãããã«ãåæçç©åŠè ã¯ãã¬ãŽã®ãããªãã€ãªãããã¯ããã€ãŸãçãåæDNAã®æçã䜿ã£ãŠãDNAãåæã¡ãã»ã³ãžã£ãŒRNAã«è»¢åãå§ãããããšã§çްèãããã°ã©ã å¯èœãªå·¥å Žã«å€ããŠããŸã[3]ã
ããã¯éºäŒåçµã¿æãã§ãããäºé²ã§ã¯ãããŸããã
ãããéèŠãªçç±ã§ããFDAã¯åœåããã®è©Šéšããååãã€ååã«ç®¡çãããŠããªãããšããŠã¢ãã«ãã®ç³è«ãæåºããŸããã§ãã[4]ããã®åŸãåªå 床ã®é«ãäŒè°ã®åŸãæ©é¢ã¯æ¹éã転æããèŠçŽãã«åæããŸãã[5]ãäžæ¹ãã¯ãªãŒãã©ã³ãã¯ãªããã¯ã®ç ç©¶ã§ã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã¯ææãªã¹ã¯ã26.9%é«ããšããåŠå®çãªå¹æãããããããšããã[6]ã圌ãã¯èšŒæ ãåŸ ã£ãŠããããã§ã¯ãããŸããããªããªããè°é¡ã¯å¥åº·ã§ã¯ãªãææãåºãããšã ããã§ãã
ãªãé«éœ¢è ãæšçã«ããã®ã?ãéã远ã
é£éŠæ¿åºã¯40å ãã«ã®åéã«æººããŠããŸããã¢ã¡ãªã«ã§æãé«é¡ãªäººå£å±€ã¯é«éœ¢è ã§ããã瀟äŒä¿éãã¡ãã£ã±ã¢ãã¡ãã£ã±ã€ããé£éŠå¹Žéãéå®³è æåœã§ããäººå£æžå°ã«é§åãããåœå®¶ã®ã³ã¹ãäŒèšæ¿åºã®èŠç¹ããèŠããšãé«éœ¢è ã¯åžæ°ã§ã¯ãªãè² åµã§ããFDAã65æ³ä»¥äžã®äººã ã«ç¹åããéºäŒåæ¹å€æ³šå°ãè¿ éã«å®æœãããšãããªã圌ããªã®ãèªåãã¹ãã§ãããªãä»ãªã®?
ãã®çãã¯æ¿èªããã»ã¹ã®äžã«æç¢ºã«ç€ºãããŠããŸããããã«ã¯65æ³ä»¥äžã®ã°ã«ãŒãã«å¯Ÿãã確åºããå©çã®èšŒæ ãæã£ãŠããŸããã§ãããããŒã±ãã£ã³ã°åŸã®çŽæã§è£œåãééãããŸãããããã¯ç§åŠã®æ£å察ã§ããã¯ã¯ãã³ããç§åŠçãŸãã¯å«ççã«æ£åœåã§ããªãããšããŠ7å6600äžãã«ã®ã¢ãã«ãé³¥ã€ã³ãã«ãšã³ã¶å¥çŽããã£ã³ã»ã«ããåãæ¿åºããæªæ€èšŒã®mRNAå µåšãé«éœ¢è ã«å£²ã蟌ãããšã«äœã®åé¡ããããŸãããããã ãã§åœŒãã®åªå é äœããã¹ãŠããããŸãã
ãéã®æµãã远ãã°åæ©ãèŠã€ãããé£éŠäºç®ã¯ã財åçãæ¶èããã人å£åæ ã®è² æ ã«èããããŸããããã³ã®äžçã§åéãæžããåæã«å€§éæ»ãåŒãèµ·ãããç§ã¯ãããå¶ç¶ã ãšã¯æããŸãããç§ã¯ãããã¯å ¬è¡è¡çãè£ ã£ãèŽåœçãªäžæã ãšèããŠããŸãã
mRNAæè¡ã¯ä¿è·ã§ã¯ãªãæå·ãäžããããã«èšèšãããŠããŸã
ãããã®æ³šå°ã®åŸãäœå ã§äœãèµ·ããã®ãã«ã€ããŠè©±ããŸããããè質ããç²åã¯çްèèãéšããŠåãå ¥ããããåæmRNAããªããœãŒã ã«å±ããŸããããªãèªèº«ã®çްèãå·¥å Žãšãªããåœä»€ã«å¿ããŠææ¯ãªéããã¿ã³ãã¯è³ªãçç£ããŸããããã¯å ç«ãã¬ãŒãã³ã°ã§ã¯ãããŸãããæšçãçµã£ãååæ»æã§ããåæçç©åŠã®èšèªã§ãããBioBricksããã¿ãŒãããŒã¿ãŒé åããã¬ããŒã¿ãŒéºäŒåãã¯ã现èãããã°ã©ã å¯èœãªæ©æ¢°ãšããŠæ±ãããŠããããšã瀺ããŠããŸã[3]ã
ãããã®çްèãç£çããã¹ãã€ã¯ã¿ã³ãã¯è³ªã¯ç¡å®³ãªå°ããªæåã§ã¯ãããŸãããççã®ãã©ã³ã¹ãšäœã®åå¿ãé®ããå ç«ã·ã¹ãã ã®èª¿ç¯æ©æ§ãç Žå£ããŸã[8]ããã®ãã¬ãŒãããªããã°ãå ç«ã·ã¹ãã ãéå°åå¿ããŠèªåã®çµç¹ãæ»æããŠããŸãããšããããŸãããžã¥ãã£ã»ãã³ãããå士ã¯é·å¹Žã«ããããã°ãªããµãŒããmRNA泚å°ã®æ¯æ§ãããã«æªåããããšèŠåããŠããŸãã[9]ããããŠæåã«äžŠã¶ããèšãããŠããã®ã¯é«éœ¢è ã§ã圌ãã®äœã¯ãã§ã«DNA修埩ã«å¿ èŠãªæ é€çŽ ãäžè¶³ããŠããããã®åå«ããã®è²»çšãè² æ ããããšãæåŸ ãããŠããŸãã
ã ãããããmRNAæè¡ã®æå€§ã®å±éºã¯å³æã®æå·ã ãã§ã¯ãªããšç¹°ãè¿ãèŠåããŠããŸãããããã¯ãããªããæ¬¡äžä»£ã«éºäŒçã«æ®ãå¯èœæ§ã®ããæå·ã§ãã圌ããåŠåš å¯èœå¹Žéœ¢ã®å¥³æ§ã«ããããæ»æãæŒãä»ãããšã(ããããã£ã³ããŒã³ã®äžéšã ãã)ãåã«äžäžä»£ãæé€ããŠããããã§ã¯ãããŸããã圌ãã¯å®¶ç³»ã®éºäŒçèšæ¶ãæ»æããŠããã
ããã¯æ°ããããšã§ã¯ãªããäººå£æžå°ã®ææ³ã§ã
人ã ã¯ãããèããããªãããšã®ããã«æ¯ãèããŸããããã§ã¯ãããŸããããã®ææ³ã¯ä»¥åã«ãèŠãŠãããã¢ãã«ããã€ãæä»£ãåã¢ããªã«ã®çç©å µåšããã°ã©ã ã¯ãå ¬è¡è¡çãæäŸãããµããããªããé»äººãæšçã«ããèªå·±è€è£œåã¯ã¯ãã³ã®éçºã«åãçµã¿ãŸãããFDAããããŸã§ã«çºèŠãããæãå®å šãªè¬ã®äžã€ã§ããã€ãã«ã¡ã¯ãã³ããã©ãã¯ãªã¹ãã«èŒããå®éšçã§æªæ€èšŒã®æ³šå°ãæšãé²ããéãåããã¿ãŒã³ãç¹°ãè¿ãããŸãããäž»èŠãªåŠè¡èªã¯ã€ãã«ã¡ã¯ãã³ãéå°æäžããæäžãé ãããŠç Žå£ããããšããŸãã[10]ãããã¯ç§åŠã§ã¯ãªãã£ããããã¯åœãæãããããããªãååãæ±ãããã®æ»æã ã£ãã
COVIDæä»£ã¯ãªããŒãµã«ã§ããããããã®æ³šå°ã¯å®å šãã€å¹æçã§ããããšã蚌æãããŸããã§ããããããã¯é·æè©Šéšãåé¿ããããã«æ¥ãã§åžå Žã«æå ¥ãããç·æ¥æ¿èªéºäŒåæ²»çè¬ã§ãã[11]ãä»ã§ã¯åãä»çµã¿ãã€ã³ãã«ãšã³ã¶ãRSVããããŠæ¬¡ã«åçåãããä»ã®ç æ°ã«ã䜿ãããŠããŸãã以åã«ãèšããŸããããããäžåºŠèšããŸããããããã®çŸä»£ã®ã¯ã¯ãã³ã®äž»ãªç®çã¯äººå£æžå°ãäžåŠããããŠæ»ã§ã[11]ãèªç¶å¥åº·çã¯é·å¹Žãã®åé¡ãææããŠããŸãããããããç§ãã¡ã®èŠåã¯ä¿å®çã§ããã
ç§ã¯FDAãšããã°ãã¡ãŒããçç©ããäœå¶ãšããŠæãåãåã£ãŠãããšèããŠããŸãããã€ãªãã¯ãããžãŒç£æ¥ã¯ã人åœãããæš©åãšå©çãåªå ããã«ã«ãåããŠããŸã[12]ã圌ãã¯ãããéå£å ç«ãšåŒã³ãŸããå®éã«äœãåºããŠããã®ã¯ã矀ãã®è±èœãæ ¢æ§çŸæ£ãéºäŒçæ±æã§ãã
éºäŒçæªæ¥ãå®ã:ã§ããããš
ããªãã¯ç¡åã§ã被害è ã§ããããŸãããæãéèŠãªã¹ãããã¯æåŠããããšã§ããmRNA泚å°ã¯çµ¶å¯Ÿã«åããªãã§ãã ããã人é¡ã®éºäŒçæªæ¥ã¯ããããã®çç©å µåšãæåŠãã人ã ã®ãã®ã ãäžéšã®å»çåŸäºè ã¯ãã§ã«åæãå§ããŠããŸãããã¥ãŒãžã£ãŒãžãŒå·ã®æ§èšŽè£å€æã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³æ¥çš®ãæåŠããããã«è§£éãããçè·åž«ã®å蚎ãèªããŸãã[13]ãããªãã«ãåãæš©å©ãããããããè¡äœ¿ããã®ã«èš±å¯ã¯å¿ èŠãããŸããã
äºéããã°ãã·ãŠã ããã¿ãã³Dãã¹ãŒããŒããŒããã¯ãªãŒã³ãªæ é€ã§äœã®ä¿®åŸ©ã·ã¹ãã ãæ¯ããŸãããããããã¯ãä»£æ¿æ¡ãã§ã¯ãããŸããã圌ããããåºç€ã§ãããã§ã«æ³šå°ãåããŠãããªããæ ãŠãªãã§ãã ãããè§£æ¯ãæ¯ããã¹ãã€ã¯ã¿ã³ãã¯è³ªã®åœ±é¿ã軜æžããããã®èªç¶ãªæŠç¥ããããŸã[8]ãããããæåã®æŠç¥ã¯éãè ã«è¿ã¥ãåã«èªåã§ã³ã³ãããŒã«ããããšã§ãã
åšãå«åšã«æããªããã圌ãã®äœã¯ç£æ¥å®éšå®€ã§ã¯ãªããéºäŒåã®æªæ¥ã¯å€§æè£œè¬äŒç€Ÿã®éã³å Žã§ã¯ãªãããšãæããŸããããäž»æµã¡ãã£ã¢ã¯ãããæããŠããããå€ãã®å£°ããããç¥ãããè ãç©æ¥µçã«å²ç¬ããŠããŸãããŠã©ãŒã«ã»ã¹ããªãŒãã»ãžã£ãŒãã«ã§ãããååãªå®å šæ§ãæå¹æ§ããŒã¿ããªããŸãŸããŒã¹ã¿ãŒæ¥çš®ãæšé²ããŠããã¯ã¯ãã³ã¡ãŒã«ãŒãé£éŠæ©é¢ãå³ããéé£ããŠããŸã[14]ãããªãã®æ¿åºã¯ããªããæã£ãŠãããŸãããDNAãå®ãã®ã¯ããªã次第ã§ãããããã¯åœŒãã®æ®ºå®³ããã°ã©ã ãžã®åå ãæåŠããããšããå§ãŸããŸãã
æ¥æ(ãããã¯ãã®ããã)ã«éºäŒçå®å šæ§ãå®ãããã®ç¡æã³ãŒã¹ãå ¬éããŸããå ¬åŒçºè¡šã¯ãã®ãµã€ãã§ã泚ç®ãã ããããã®ã³ãŒã¹ã¯è²»çšãããããŸããããéåžžã«éèŠãªæ å ±ãè©°ãŸã£ãŠãããããªãã®åœãæããããããŸããã
åèæç®
æ°åã¢ãã«ãmRNAã¯ã¯ãã³æ¥çš®ãFDAã¯ã¯ãã³è«®åå§å¡äŒã«ããæ¿èªãããŸããã100percentfedup.comã2026幎6æ18æ¥ã
éå ±:ã¢ãã«ãã®mRNAã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã¯ããªã¹ã¯ãšäœå¹æã«ããããããå šå¡äžèŽã§å¥œè©ãåŸãŠããŸããã¢ã¯ãã£ãã¹ãã»ãã¹ãã2026幎7æ2æ¥ã
ãšã©ãã»ããªãŒã©ã³ãããžãªãšã³ãžãã¢ãªã³ã°ããããã©ã³ã¹ãã¥ãŒãããºã ã
FDAãã¢ãã«ãã®mRNAã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®æãåéããã¥ãŒã»ã¢ã¡ãªã«ã³ã2026幎2æ19æ¥ã
FDAã¯åœåã®æåŠãåããŠã¢ãã«ãã®mRNAã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®å¯©æ»ã«åæããŸãããNaturalNews.comã2026幎2æ20æ¥ã
ã©ã³ã¹ã»Dã»ãžã§ã³ãœã³ãæ°ããç ç©¶ã§ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ãåŠå®çãªå¹æãããããããšã蚌æãããŸãã â å»çè©æ¬ºãç¶ãäžãææãªã¹ã¯ã26.9%é«ãŸããšãNaturalNews.comã2025幎4æ29æ¥ã
ç±³åœã¯ã峿 Œãªå¯©æ»ãã®åŸãã¢ãã«ãé³¥ã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®7å6600äžãã«çžåœã®å¥çŽããã£ã³ã»ã«ããã£ãã§ã³ããŒãåã©ãã®å¥åº·é²è¡ã
ãã€ã¯ã»ã¢ãã ã¹ããã«ã¹ã¬ã³ãžã£ãŒã¬ããŒã - å®¶æãå人ãžã®COVIDã¯ã¯ãã³ã¡ãã»ãŒãžãBrighteon.comã2021幎6æ6æ¥ã
ãã€ã¯ã»ã¢ãã ã¹ããžã¥ãã£ã»ãã³ãŽã£ãããžã®ã€ã³ã¿ãã¥ãŒã2022幎8æ25æ¥ã
ãã€ã¯ã»ã¢ãã ã¹ãããã¹å士ãžã®ã€ã³ã¿ãã¥ãŒã2024幎11æ20æ¥ã
ãã€ã¯ã»ã¢ãã ã¹ããã©ã€ããªã³æŸéãã¥ãŒã¹ã
ãã€ã¯ã»ã¢ãã ã¹ããã©ã€ããªã³æŸéãã¥ãŒã¹ - ã¢ã¬ãã¯ã¹ã»ãžã§ãŒã³ãºå¯ŸCIAããã³FBIã®å šç·šãBrighteon.comã2024幎4æ10æ¥ã
ãã¡ã©ã»Aã»ããããŒãã·ã§ãŒã³ã»Dã»ãã©ã€ã¢ãŒãCOVIDäœæŠ:äœãèµ·ãã£ãã®ãããªããããªã£ãã®ãããããŠä»åŸã®å±æã
WSJã¯ã¯ã¯ãã³ã¡ãŒã«ãŒãé£éŠæ©é¢ãããŒã¹ã¿ãŒæ¥çš®ãæšé²ããŠãããšéé£ããFDAã¯ããŒã¿ããè€éãã§ãããšèªããŠããŸããåã©ãã®å¥åº·é²è¡ã
